+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-12-06Number of Pages: 172

Drugs of Abuse Testing Market (Products - Analyzers (Immunoassays Analyzers, Chromatographic Devices, and Breath Analyzers), Rapid Testing Devices (Urine Testing Devices and Oral Fluid Testing Devices), and Consumables (Fluid Collection Devices); Sample - Saliva, Breath, Urine, Blood, Hair, and Sweat; Testing - Pain Management Testing, Criminal Justice Testing, and Work Place Screening; End User - Forensic Laboratories, Diagnostic Labs, On-the-spot Testing, Hospitals, and Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Drugs of Abuse Testing Market: Snapshot

Drugs of abuse testing offer a variety of testing methods that can be conducted at home as well as in laboratories to detect drugs present in the human body. These drugs are tested through saliva, blood, and sweat.  The testing of drugs is done for drugs that are banned by governments. Analysts anticipate that the global market will witness a considerable growth rate in the coming years due to rising prevalence of drug abuse. According to the research report, the global drugs is projected to reach US$6.4 bn by the end of 2024 as against US$4.1 bn in 2015. During the forecast years of 2016 and 2024, the global market is estimated to progress at a CAGR of 5.3%.

drugs abuse testing market

 

Rise in Drug Abuse Ensures Swift Uptake of Testing Products

The global market for drugs of abuse testing has witnessed a prolific growth over the past few years due to the increasing abuse of illicit drugs and alcohol in various parts of the world. The harmful effects of drug abuse to the society has been the primary growth driver for the increasing uptake of drugs of abuse testing products. The market is also thriving due to emergence of testing laboratories in recent times. The growing pressure on the corporate world to ensure that the work environment is safe for their employees and devoid of illicit activities, offices across the globe are also conducting workplace screening. Analysts predict the growing number initiatives by governments across the globe along with non-profit organization to reduce the levels of drug abuse will have a positive impact on the overall market.

The global drugs of abuse testing market uses samples such as breath, saliva, sweat, urine, blood, and hair to test for presence of drugs in the human body. Of all these, the urine sample type segment accounted for a lion’s share in the global market of 43.8% in 2015. The saliva sample type segment followed next with a share of 24.2% in the overall market in 2015.

On the basis of testing type the global drugs of abuse market is segmented into criminal justice testing, pain management testing, and work place screening. As of 2015, the criminal justice testing segment held a share of 39.7% in the overall market. Amongst the end users, the forensic laboratories segment held a leading share of 42.5% in the global drugs of abuse testing market in 2015.

Stringent Government Norms across North America Boost Regional Market

In terms of geography, the global market is divided into Asia Pacific, Latin America, the Middle East and Africa, Europe, and North America. Of these North America held a mammoth share in the global market. The regional market accounted for 49.3% of the overall market due to stringent rules pertaining to the use of illicit drugs. Europe is also anticipated to show a steady growth rate in the overall market due to high incidence of abuse of prescription drugs.

The research report profiles some of the leading companies operating in the global drugs of abuse testing market and provides a thorough explanation of their financial outlook, research and development activities, and business and marketing strategies. The key players identified in the global market are Laboratory Corporation of America Holdings, Alere Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., Siemens Healthcare, Drägerwerk AG & Co. KGaA, Shimadzu Corporation, and Express Diagnostics International Inc.

Global Drugs of Abuse Testing Market: Scope and Methodology

This report on the global drugs of abuse testing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global drugs of abuse testing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

 A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global drugs of abuse testing market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of product and product features of different types. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing demand for drug abuse testing in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Drugs of Abuse Testing Market: Segmentation

Based on product type, the global drugs of abuse testing market has been segmented three major sub segments namely, analyzers, rapid testing devices and consumables. The analyzers product type segment is further sub – segmented into immunoassay analyzers, chromatographic devices and breath analyzers. The rapid testing devices product type segment is further sub segmented into urine testing devices and oral fluid testing devices. The consumables product type segment is further sub – segmented into fluid collection devices and others. The market has been further studied from the point of view of sample type.

Based on sample type, the market has been segmented into saliva, breath, urine, blood, hair & sweat. On the basis of testing type, the market has been segmented into pain management testing, criminal justice testing and work place screening. Based on the end users the market is categorized into hospitals, diagnostics laboratories, on-the-spot testing and forensic laboratories.

Drugs of Abuse Testing Market: Geographical Outlook

Geographically, the global drugs – of – abuse testing market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, GCC Countries, South Africa, Brazil, and Mexico.

Key Players Mentioned in the Report are:

The report also profiles major players in the drugs of abuse testing market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Alere Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthcare, Express Diagnostics International Inc. and Shimadzu Corporation.

The global drugs of abuse testing market has been segmented as follows:

Global Drugs of Abuse Testing Market, by Product Type

  •  Analyzers
    • Immunoassays Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
    • Fluid Collection Devices
    • Others

Global Drugs of Abuse Testing Market, by Sample Type

  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

Global Drugs of Abuse Testing Market, by Testing Type

  • Pain Management Testing
  • Criminal Justice Testing
  • Work Place Screening

Global Drugs of Abuse Testing Market, by End User

  • Hospitals
  • Diagnostics Laboratories
  • On-the-spot Testing
  • Forensic Laboratories

Global Drugs of Abuse Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa


 
 
Back To Top